Arroyo Grande Community

Arroyo Grande, California 93420

0 studies enrolling now · 5 studies all time

What they study most

Breast Adenocarcinoma, Colorectal Neuroendocrine Tumor G1, Estrogen Receptor Positive, Extensive Stage Lung Small Cell Carcinoma, Gastric Neuroendocrine Tumor G1, HER2 Positive Breast Carcinoma, HER2/Neu Negative, Hormone Receptor Positive, Neuroendocrine Neoplasm, Neuroendocrine Tumor, Neuroendocrine Tumor G2, Progesterone Receptor Positive

Studies at this site

• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) — Running, not enrolling
• Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor — Running, not enrolling
• Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer — Completed
• Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer — Completed
• Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive — Completed